Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients.
CONCLUSION: Although LC-MS provides a more accurate representation of the blood concentration of the parent compound tacrolimus exclusive of metabolite, established cut points for tacrolimus dosing may need to be adjusted to account for the increased risk of renal injury.
PMID: 31696925 [PubMed - as supplied by publisher]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Kolaitis NA, Calabrese DR, Ahearn P, Venado A, Florez R, Lei HL, Isaak K, Henricksen E, Martinez E, Chong T, Shah RJ, Leard LE, Kleinhenz ME, Golden J, De Marco T, Greenland JR, Kukreja J, Hays SR, Blanc PD, Singer JP Tags: Am J Health Syst Pharm Source Type: research
More News: Academia | Bone Graft | Diabetes | Drugs & Pharmacology | Endocrinology | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Lung Transplant | Prograf | Renal Failure | Statistics | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology | USA Health